Satsuma Pharmaceuticals, Inc.
(NASDAQ : STSA)

( )
STSA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. 0.35%94.362.3%$1034.63m
MRKMerck & Co., Inc. 0.07%82.700.7%$1012.87m
JNJJohnson & Johnson 0.07%150.200.7%$999.04m
PFEPfizer Inc. -0.08%36.470.9%$957.29m
BMYBristol-Myers Squibb Co. -0.06%66.351.0%$857.71m
LLYEli Lilly & Co. 0.00%141.161.1%$489.93m
NVSNovartis AG -0.71%96.960.2%$217.05m
GSKGlaxoSmithKline Plc -0.91%43.340.2%$163.86m
AZNAstraZeneca Plc 2.34%48.971.2%$139.67m
RETAReata Pharmaceuticals, Inc. -1.90%225.653.5%$96.60m
NVONovo Nordisk A/S 0.95%64.040.1%$85.24m
BHCBausch Health Cos., Inc. 0.49%27.880.0%$79.45m
SNYSanofi 0.48%50.170.2%$76.61m
GNPXGenprex, Inc. 3.51%4.430.0%$72.79m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.31%45.200.0%$62.02m

Company Profile

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.